Abstract:Background: Cancers, a group of multifactorial complex diseases, are generally caused by mutation of multiple genes or dysregulation of pathways. Identifying biomarkers that can characterize cancers would help to understand and diagnose cancers. Traditional computational methods that detect genes differentially expressed between cancer and normal samples fail to work due to small sample size and independent assumption among genes. On the other hand, genes work in concert to perform their functions. Therefore, it is expected that dysregulated pathways will serve as better biomarkers compared with single genes.Results: In this paper, we propose a novel approach to identify dysregulated pathways in cancer based on a pathway interaction network. Our contribution is three-fold. Firstly, we present a new method to construct pathway interaction network based on gene expression, protein-protein interactions and cellular pathways. Secondly, the identification of dysregulated pathways in cancer is treated as a feature selection problem, which is biologically reasonable and easy to interpret. Thirdly, the dysregulated pathways are identified as subnetworks from the pathway interaction networks, where the subnetworks characterize very well the functional dependency or crosstalk between pathways. The benchmarking results on several distinct cancer datasets demonstrate that our method can obtain more reliable and accurate results compared with existing state of the art methods. Further functional analysis and independent literature evidence also confirm that our identified potential pathogenic pathways are biologically reasonable, indicating the effectiveness of our method.Conclusions: Dysregulated pathways can serve as better biomarkers compared with single genes. In this work, by utilizing pathway interaction networks and gene expression data, we propose a novel approach that effectively identifies dysregulated pathways, which can not only be used as biomarkers to diagnose cancers but also serve as potential drug targets in the future.

A human functional protein interaction network and its application to cancer data analysis

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Discovering Distinct Functional Modules of Specific Cancer Types Using Protein-Protein Interaction Networks

A Network-Based Pathway-Expanding Approach for Pathway Analysis

Functional Interaction Network Construction and Analysis for Disease Discovery

Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.

Reconstruction of human protein-coding gene functional association network based on machine learning

A Network-Based Analysis for Mining the Risk Pathways in Glioblastoma

Bioinformatics Analysis of High-Throughput Data to Validate Potential Novel Biomarkers and Small Molecule Drugs for Glioblastoma Multiforme

A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups

Network-based cancer genomic data integration for pattern discovery

Pathway Network Analysis of Complex Diseases Based on Multiple Biological Networks.

Identifying Dysregulated Pathways in Cancers from Pathway Interaction Networks

Identifying novel glioma associated pathways based on systems biology level meta-analysis

Atbionet– an Integrated Network Analysis Tool for Genomics and Biomarker Discovery

Identification of Driver Network Modules in Protein-Protein Interaction Network Using Patient Mutation Profiles

A Heterogeneous Network Based Method for Identifying GBM-Related Genes by Integrating Multi-Dimensional Data.

Drug Screening and Biomarker Gene Investigation in Cancer Therapy Through the Human Transcriptional Regulatory Network

Large-scale Integrative Network-Based Analysis Identifies Common Pathways Disrupted by Copy Number Alterations Across Cancers

Identification of Key Candidate Genes and Pathways in Glioblastoma by Integrated Bioinformatical Analysis